NEW SURVEY SHOWS PATIENTS WITH IRRITABLE BOWEL SYNDROME SUFFER FROM SEVERE SYMPTOMS AFFECTING ACTIVITIES OF DAILY LIVING

International Foundation for Functional Gastrointestinal Disorders Presents Results to FDA Advisory Committee

For Immediate Release

Media Contact form
IFFGD
414-964-1799

MILWAUKEE, WI (April 23, 2002) - Today, during the FDA Advisory Committee meeting, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) released the results of its IBS in the Real World survey showing the real life impact Irritable Bowel Syndrome (IBS) has on the lives of those who suffer with the disease. Results of the survey indicated substantial reduction in the quality of life and activities of daily living for patients with IBS.

IFFGD's quantitative study includes data drawn from 350 adults of the IFFGD patient database. Results of the survey reveal that nearly half of IBS sufferers polled reported daily episodes of IBS symptoms and more than one-third rated the pain associated with IBS symptoms as extreme. Additionally, more than one-quarter of survey respondents reported missing work or school due to IBS symptoms in the past three months, illustrating the challenges these patients face everyday and further highlighting the need for safe and effective treatments.

"The findings of the IBS in the Real World survey bring to light the tremendous human impact of IBS, said Nancy Norton, President and Founder of IFFGD. "Chronic and recurring symptoms of IBS can disrupt personal and professional activities, upset emotional well-being and limit individual potential, with some respondents in the survey receiving disability due to their IBS. Since there is currently no cure for IBS, it is imperative that the best ways to manage and treat this disease are made available to patients so they can enjoy a normal, active life."

About IBS

Irritable bowel syndrome is a functional disease characterized by chronic and recurrent abdominal pain and abnormal bowel function. IBS sufferers have unusually sensitive and active nerve endings in the lining of the bowel that trigger inappropriate muscle activity, resulting in episodes of diarrhea, constipation, or both in alternation. The cause of IBS is not known, and as yet there is no known cure.

About the Survey

The survey was conducted from February 6 - March 2, 2002 with 350 patients, each of whom had previously received a diagnosis of IBS. Nearly half (47%) of IBS sufferers in the study reported daily episodes of IBS symptoms with more than one third (39%) reporting extreme or very severe pain. More than one quarter (26%) of the participants reported absenteeism from work or school due to IBS symptoms in the last three months and 5% of respondents reported being on disability due to their IBS.

IBS sufferers in the survey reported using 281 different treatments, including prescription drugs, over-the-counter (OTC) medications and herbal and dietary supplements, to control their symptoms. However, less than one-third reported satisfaction with the drugs and remedies they use to treat their symptoms. Of those taking prescription drugs, 62% report side effects, with almost half (45%) reporting the side effects as severe or moderate, thus illustrating the need for more effective treatments. Of those respondents reporting side effects:

The survey results reveal the often hidden real world of IBS patients. More information about the survey is available online at www.iffgd.org/Research/IBS2002Survey.html or by calling their toll-free hotline at 1-888-964-2001.

The IFFGD is a nonprofit education and research organization whose mission it is to inform, assist and support those affected by gastrointestinal disorders. With an international group of experts from multiple disciplines who serve on the organization's medical advisory board, the IFFGD is a resource for anyone seeking current information about gastrointestinal disorders for both adults and children.

  • 12% had to visit an ER
  • 7% were hospitalized
  • 29% had to call their health care provider, and
  • 24% had to visit their health care provider
  • 22% had to stop driving
  • 18% reported missing work or school

###

News
Industry Treatment News
Eluxadoline (Viberzi)
Eosinophilic Esophagitis Study
Gattex
Linaclotide (Linzess)
Linaclotide Study for IBS in Children
Linaclotide Study for FC in Children
Medical News
Medical News - Archive
Events
Special Events & Meetings
Press Releases
2016-1115 GERD is More Than Simple Heartburn
2014-1119 Persistent Heartburn May Be a Sign of GERD
2013-1106 15 Tips for GERD Awareness Week
2010-1118 GERD Difference
2010-1001 Heartburn or GERD?
2009-1109 GERD at Night
2006-1116 GERD & Holidays
2005-1125 GERD Costs
2003-1117 GERD Treatment
2016-0801 Learn the Facts About Gastroparesis
2016-0405 Think You Have IBS? Find Out For Sure Before Starting a Treatment
2015-1123 Is it More than Simple Heartburn? Ask Your Doctor.
2015-7-30 Gastroparesis is a Hidden Medical Condition for Many
2015-0330 Online Survey Looks to Help Improve Outcomes for those with IBS
2014-0826 Lack of Awareness of Gastroparesis May Impact Medical Care
2014-0326 IFFGD Marks IBS Awareness Month with Launch of Mobile App
2014-0225 IFFGD Research Grants to Study Gastroparesis
2013-0626 New DHA.org
2013-0412 IFFGD Presents 2013 Research Awards
2013-0401 Turning Attention to Returning Vets
2012-1109 Banish Frequent Heartburn by Burning More Calories
2012-0321 April is IBS Awareness Month: A Serious Issue for Veterans
2011-1130 Is Your Child's Reflux/Spitting Up A Point of Concern?
2011-0412 IFFGD Research Award Winners
2011-0329 IBS Signs You Should Not Ignore
2010-0517 US House Resolution for IBS
2009-0417 IFFGD Research Award Recipients
2008-0331 Dealing with Digestive Disorders
2007-1118 When Is Simple Heartburn Not So Simple?
2007-0718 Proposed FDA Funding Applauded
2007-0401 IBS Myths
2006-0202 IBS or Something Else
2006-0418 Natl Commission
2006-0321 Women's Health
2005-0412 IBS Awareness
2004-1125 Heartburn & Heartache
2004-0929 Norton Honored
2004-0408 IBS Medical Care
2004-0525 IBS Travel Tips
2004-0101 IFFGD Conference
2003-0401 IFFGD Research Awards
2003-0401 IBS Awareness
2002-1102 Heartburn Caution
2002-0423 IBS in Real World
2002-0423 IBS-C Treatment
2002-0402 IBS & Lost Potential
2001-1119 Heartburn or Heart Attack
2001-0322 Patients First
1998-0401 IBS Millions Suffer
1997-1114 Research & Women's Health
Commentary
Misunderstood Functional GI Disorders
IBS is No Joking Matter
For Media
Reporters' Guides
Media Contact Form

Our Mission

healthy family

Education and Research

Our mission is to inform, assist and support people affected by gastrointestinal (GI) disorders.

IFFGD works with patients, families, physicians, health care professionals, and others to broaden understanding about gastrointestinal disorders and support or encourage research.

Awareness Activities & Accomplishments

Advocacy Activities

IFFGD Research Award